TY - JOUR
T1 - Predicting the future of TAVR
T2 - an obituary to open aortic valve replacement?
AU - Shreenivas, Satya
AU - Kaneko, Tsuyoshi
AU - Tang, Gilbert H.L.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - PURPOSE OF REVIEW: Transcatheter aortic valve replacement (TAVR) has become the cornerstone for aortic valve intervention since the first implantation in 2002. Recent advances with novel devices and introduction into lower risk cohorts have been successful. In this review, we discuss the ongoing limitations to transcatheter aortic valve therapy and whether it will replace surgical aortic valve replacement in the foreseeable future. RECENT FINDINGS: A better understanding of valve durability, high-grade heart block, and stroke post TAVR has led to practice changes that improve patient outcome. SUMMARY: Although there has been great progress made in treating severe aortic stenosis with TAVR, there are room for improvements before it becomes the default therapy for all patients.
AB - PURPOSE OF REVIEW: Transcatheter aortic valve replacement (TAVR) has become the cornerstone for aortic valve intervention since the first implantation in 2002. Recent advances with novel devices and introduction into lower risk cohorts have been successful. In this review, we discuss the ongoing limitations to transcatheter aortic valve therapy and whether it will replace surgical aortic valve replacement in the foreseeable future. RECENT FINDINGS: A better understanding of valve durability, high-grade heart block, and stroke post TAVR has led to practice changes that improve patient outcome. SUMMARY: Although there has been great progress made in treating severe aortic stenosis with TAVR, there are room for improvements before it becomes the default therapy for all patients.
UR - http://www.scopus.com/inward/record.url?scp=85061114499&partnerID=8YFLogxK
U2 - 10.1097/HCO.0000000000000609
DO - 10.1097/HCO.0000000000000609
M3 - Article
C2 - 30640745
AN - SCOPUS:85061114499
SN - 0268-4705
VL - 34
SP - 112
EP - 123
JO - Current Opinion in Cardiology
JF - Current Opinion in Cardiology
IS - 2
ER -